ORIC
Oric Pharmaceuticals Inc
NASDAQ: ORIC · HEALTHCARE · BIOTECHNOLOGY
$9.88
+4.66% today
Updated 2026-04-30
Market cap
$977.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.47
Dividend yield
—
52W range
$5 – $15
Volume
2.1M
Oric Pharmaceuticals Inc (ORIC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-41.30%
ROA
-26.20%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-22.03M | — | — | — |
| 2018 | $0.00 | $-21.36M | — | — | — |
| 2019 | $0.00 | $-26.88M | — | — | — |
| 2020 | $0.00 | $-73.70M | — | — | — |
| 2021 | $0.00 | $-77.68M | — | — | — |
| 2022 | $0.00 | $-89.12M | — | — | — |
| 2023 | $0.00 | $-100.70M | — | — | — |
| 2024 | $0.00 | $-127.85M | — | — | — |
| 2025 | $0.00 | $-129.47M | — | — | — |